Currently, Palvella Therapeutics Inc [PVLA] is trading at $36.0, up 16.13%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The PVLA shares have gain 29.96% over the last week, with a monthly amount glided 63.27%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Palvella Therapeutics Inc [NASDAQ: PVLA] stock has seen the most recent analyst activity on July 21, 2025, when Truist initiated its Buy rating and assigned the stock a price target of $56. Previously, Chardan Capital Markets started tracking the stock with Buy rating on April 09, 2025, and set its price target to $50. On March 26, 2025, Stifel initiated with a Buy rating and assigned a price target of $45 on the stock. Scotiabank started tracking the stock assigning a Sector Outperform rating and suggested a price target of $50 on March 07, 2025. Canaccord Genuity initiated its recommendation with a Buy and recommended $39 as its price target on February 20, 2025. TD Cowen started tracking with a Buy rating for this stock on February 05, 2025, and assigned it a price target of $44. In a note dated December 26, 2024, H.C. Wainwright initiated an Buy rating and provided a target price of $38 on this stock.
This stock has fluctuated between a low of $7.30 and a high of $31.50 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $48.5 within the next 12 months. Palvella Therapeutics Inc [NASDAQ: PVLA] shares were valued at $36.0 at the most recent close of the market. An investor can expect a potential return of 34.72% based on the average PVLA price forecast.
Analyzing the PVLA fundamentals
Trailing Twelve Months sales for Palvella Therapeutics Inc [NASDAQ:PVLA] were 1.35M which represents -100.00% decline. To continue investigating profitability, this company’s Return on Assets is posted at -0.2, Equity is -0.59 and Total Capital is -0.18.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 32.60 points at the first support level, and at 29.21 for the second support level. However, for the 1st resistance point, the stock is sitting at 37.80, and for the 2nd resistance point, it is at 39.60.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Palvella Therapeutics Inc [NASDAQ:PVLA] is 8.84. Also, the Quick Ratio is 8.84, while the Cash Ratio stands at 6.94. Considering the valuation of this stock, the price to sales ratio is 294.82, the price to book ratio is 7.14.
Transactions by insiders
Recent insider trading involved JENKINS GEORGE M, Director, that happened on Apr 09 ’25 when 2490.0 shares were purchased. Director, JENKINS GEORGE M completed a deal on Apr 09 ’25 to buy 2500.0 shares. Meanwhile, Director JENKINS GEORGE M bought 4000.0 shares on Dec 18 ’24.
